tDCS and Varenicline for Quitting Smoking
tDCS Plus Varenicline for Smoking Cessation
Recruiting
Phase 4
Interventional Study
Nicotine Dependence
Tobacco Smoking
Smoking Cessation
Nicotine Use Disorder
Tobacco Use Disorder
Substance Use Disorders
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Centre for Addiction and Mental Health · Other
Who this trial is looking for
This trial is looking for adults who want to quit smoking. Participants will receive daily treatment for two weeks and then follow-up sessions to check on their progress.
Are You a Good Fit for This Trial?
You may be able to join if
- I can provide written consent
- I am willing to follow study procedures
- I am between 18 and 85 years old
- I smoke at least 8 cigarettes a day
- I want help to quit smoking
- I can attend the required clinic visits for two weeks
- I am otherwise healthy
You may not be able to join if
- I have used smoking cessation medication in the past 3 months
- I currently use nicotine products besides cigarettes
- I have an unstable psychiatric illness
- I have a history of seizures or epilepsy
- I have had concussions or head injuries
- I am currently pregnant or planning to become pregnant
- I have a pacemaker or other implanted device
- I have metal in my skull
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine if active transcranial direct current stimulation (tDCS) plus varenicline is an effective, safe and accessible treatment option for smoking cessation. The main questions this trial aims to answer are:
1. Does active tDCS plus varenicline improve short-term and long-term smoking abstinence rates compared to sham tDCS plus varenicline?
2. Are the safe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Be able to provide informed written consent
* Stated willingness to comply with all study procedures
* Age 18-85 years
* Smoke ≥ 8 cigarettes per day (CPD)
* Is seeking treatment for tobacco dependence
* Willing to attend the required clinic appointments (Two consecutive weeks…
Contacts